Increased mitochondrial ATP production capacity in brain of healthy mice and a mouse model of isolated complex I deficiency after isoflurane anesthesia by Manjeri, G.R. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/167305
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
ORIGINAL ARTICLE
Increased mitochondrial ATP production capacity in brain
of healthy mice and a mouse model of isolated complex I
deficiency after isoflurane anesthesia
Ganesh R. Manjeri1,2 & Richard J. Rodenburg2 & Lionel Blanchet1 &
Suzanne Roelofs3 & Leo G. Nijtmans2 & Jan A. Smeitink2 &
Jacques J. Driessen3 & Werner J. H. Koopman1 & Peter H. Willems1
Received: 24 April 2015 /Revised: 22 July 2015 /Accepted: 23 July 2015 /Published online: 27 August 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract We reported before that the minimal alveolar
concentration (MAC) of isoflurane is decreased in complex
I-deficient mice lacking the NDUFS4 subunit of the respira-
tory chain (RC) (1.55 and 0.81% at postnatal (PN) 22–25 days
and 1.68 and 0.65 % at PN 31–34 days for wildtype (WT) and
CI-deficient KO, respectively). A more severe respiratory
depression was caused by 1.0 MAC isoflurane in KO
mice (respiratory rate values of 86 and 45 at PN 22–25 days
and 69 and 29 at PN 31–34 days for anesthetized WT
and KO, respectively). Here, we address the idea that
isoflurane anesthesia causes a much larger decrease in
brain mitochondrial ATP production in KO mice thus
explaining their increased sensitivity to this anesthetic.
Brains from WT and KO mice of the above study were re-
moved immediately after MAC determination at PN 31–
34 days and a mitochondria-enriched fraction was prepared.
Aliquots were used for measurement of maximal ATP
production in the presence of pyruvate, malate, ADP
and creatine and, after freeze-thawing, the maximal activity
of the individual RC complexes in the presence of complex-
specific substrates. CI activity was dramatically decreased in
KO, whereas ATP production was decreased by only 26 %
(p<0.05). The activities of CII, CIII, and CIV were the same
for WT and KO. Isoflurane anesthesia decreased the activity
of CI by 30% (p<0.001) inWT. In sharp contrast, it increased
the activity of CII by 37 % (p<0.001) and 50 % (p<0.001)
and that of CIII by 37 % (p<0.001) and 40 % (p<0.001) in
WTand KO, respectively, whereas it tended to increase that of
CIV in bothWTand KO. Isoflurane anesthesia increased ATP
production by 52 and 69 % in WT (p<0.05) and KO
(p<0.01), respectively. Together these findings indicate that
isoflurane anesthesia interferes positively rather than negative-
ly with the ability of CI-deficient mice brain mitochondria to
convert their main substrate pyruvate into ATP.
Introduction
Inhaled anesthetics such as isoflurane and sevoflurane are ex-
tensively used in clinical practice but much concern remains
regarding their possible detrimental effects, particularly on the
developing brain (Loepke and Soriano 2008; Hays and
Deshpande 2011; Chiao and Zuo 2014). Recent work
shows that these anesthetics can induce mitochondrial
fission in the developing brain, suggesting a mitochondrial
component in the process of anesthesia-induced brain damage
(Boscolo et al 2013).
Further evidence for a putative role of mitochondria in the
process of anesthesia-induced brain damage comes from the
observation that children with a deficiency of complex I (CI),
but not complex III (CIII), of the respiratory chain (RC), are
hypersensitive to volatile anesthetics (Morgan et al 2002;
Driessen et al 2007). However, it is still debated whether these
anesthetics put CI-deficient children at increased risk of
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neurological complications (Niezgoda and Morgan 2013).
Recent studies with mice genetically engineered to lack the
NDUFS4 subunit of CI of the RC (referred to herein as “CI-
deficient KO mice”) corroborate the finding that the sensitiv-
ity to volatile anesthetics is increased in CI deficiency
(Quintana et al 2012a, b; Roelofs et al 2014).
Regarding a putative role of CI in the mechanism of action
of volatile anesthetics, studies investigating the effects of di-
rect application of these anesthetics to intact and broken mi-
tochondria conclude that low concentrations reversibly inhibit
the oxidation of CI-, but not CII-, linked substrates (Miller and
Hunter 1970; Harris et al 1971). Another line of evidence
supporting a direct action of volatile anesthetics on CI comes
from studies with C. elegans. This organism does not possess
specialized respiratory systems and complex circulatory or-
gans and relies entirely on the diffusion of gases across the
gut lumen and the cuticle (Van Voorhies and Ward 2000).
Loss-of-function mutations in CI, but not CII, genes, render
these worms hypersensitive to volatile anesthetics in terms of
immobility induction (Kayser et al 1999; Falk et al 2006).
Analysis of several CI-deficient worm strains with different
oxidation rates of CI-linked substrates revealed that the anes-
thetic sensitivity increased with decreasing oxidation rate
(Falk et al 2006). In agreement with these observations,
isoflurane was demonstrated to bind to a site distal to the
flavoprotein subcomplex of CI (Kayser et al 2011). Taken
together, these studies indicate that volatile anesthetics bind
to CI to reduce its activity and that this inhibitory effect is
increased by loss-of-function mutations in CI.
The RC generates the proton motive force used by CV
(F0F1-ATP synthase) to produce ATP and with the activity
of CI being reduced in CI-deficient KO mice and CI being a
direct target of volatile anesthetics, it is speculated that these
anesthetics reduce brain mitochondrial ATP production to a
much larger extent in these KO mice than in WT mice. As a
consequence, brain ATP levels would be much more de-
creased in anesthetized KO mice thus explaining their in-
creased sensitivity to volatile anesthetics (Kayser et al 2004).
To test this idea, we determined the maximal rate of ATP
production and the maximal activity of the individual RC
complexes in a whole brain mitochondria-enriched fraction
from the WT and CI-deficient KO mice described in the pre-
vious study (Roelofs et al 2014).
We show that in vivo treatment ofWTmice with isoflurane
decreased the maximal activity of CI, while it increased max-
imal ATP production. Isoflurane anesthesia also increased
maximal ATP production in CI-deficient KO mice. In both
WT and KO mice, the effect of isoflurane on brain mitochon-
drial ATP production was accompanied by an increase in CII
and CIII maximal activity and a tendency to increase for CIV.
Our data show that isoflurane anesthesia improves rather than
worsens the ATP generating ability of brain mitochondria in
both WT and CI-deficient KO mice.
Materials and methods
All experiments were approved by the Regional Animal
Ethics Committee (Nijmegen, The Netherlands) and per-
formed under the guidelines of the Dutch Council for
Animal Care. All efforts were made to reduce animal suffering
and number of animals used in this study.
Animals
This study uses the brains from the WT (ndufs4+/+) and
KO (ndufs4-/-) mice included in our previous study on
the anesthetic and respiratory depressant effects of
isoflurane (Roelofs et al 2014). The genotype of the
mice was confirmed by polymerase chain reaction and
both male and female mice were included. Mice were
group-housed at the central animal facility (CDL) of the
Radboud University at 22 °C on a day and night rhythm of
12 h. The animals had ad libitum access to food and water and
were fed on a standard animal diet (Ssniff GmbH, Soest, 76.
Germany. V1534-300 R/M-H).
Isoflurane administration
WT (n=5) and KO (n=7) mice were subjected twice, i.e., at
PN 22–25 and PN 31–34 days, to a well-established anesthe-
sia protocol to determine the minimal alveolar concentration
(MAC) of isoflurane (Roelofs et al 2014). Briefly, the
isoflurane concentration was increased with steps of 0.2 %
until the response to electrical stimulation of the hind paw
was lost. When this point was reached the isoflurane concen-
tration was decreased until return of the response. After the
first MAC determination at PN 22–25 days, the animals were
returned to their housing and determination of the MAC was
repeated at PN 31–34 days.
Tissue harvesting for biochemical analyses
Animals were sacrificed at PN 31–34 days by cervical dislo-
cation. Isoflurane-treated mice were sacrificed immediately
after determination of the MAC at PN 31–34 days. Whole
brains were transferred to ice-cold SEF buffer (0.25 mol/L
sucrose, 2 mmol/L EDTA, 10 mmol/L potassium phosphate,
pH 7.4), minced with a Sorvall TC2 tissue chopper and ho-
mogenized with a glass/Teflon Potter Elvehjem homogenizer
within 1 h of harvest. The homogenate was centrifuged at
600 g and a portion of the supernatant was used for measure-
ment of the maximal rates of pyruvate oxidation and
ATP production. The remainder of the 600 g superna-
tant was frozen in 10 μl aliquots in liquid nitrogen and kept
at −80 ° C for maximal enzymatic activity measurements. The
protein concentration was measured according to Rodenburg
(Rodenburg 2011).
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Pyruvate oxidation and ATP production measurements
To determine the maximal rate of pyruvate oxidation, the
freshly prepared 600 g supernatant was incubated with
radiolabeled substrate ([1-14C] pyruvate). After 20 min the
reaction was stopped and the amount of liberated radioactive
CO2 (
14CO2) was quantified (Janssen et al 2006). The assay
medium (pH 7.4) contained K+- phosphate buffer (30 mM;
source of Pi), KCl (75 mM), Tris (8 mM), K-EDTA (1.6 mM),
P1,P5-Di (adenosine-5′) pentaphosphate (Ap5A; 0.2 mM),
MgCl2 (0.5 mM), ADP (2 mM), creatine (20 mM), malate
(1 mM), and [1-14C] pyruvate (1 mM). AP5A is a potent
adenylate kinase inhibitor required to prevent interference of
the adenylate kinase reaction with the levels of produced ATP,
as well as with the excess of ADP required for this assay. For
measurement of the maximal rate of ATP production, the same
assay medium was used but with pyruvate instead of [1-14C]
pyruvate. After 20 min, the reaction was stopped by addition
of 0.1 M HClO4. The reaction mixture was centrifuged at 14,
000 g for 2 min at 2 °C. To the supernatant, 1.2 vol (V/V) of
0.333 M KHCO3 was added, and this mixture was diluted
twofold. The amount of ATP and phosphocreatine formed
during the reaction were measured in the supernatant
using a Konelab 20XT auto-analyzer (Thermo Scientific).
Mitochondrial ATP production rate was corrected using a par-
allel assay in which residual glycolysis was blocked by arse-
nite (2 mM) (Janssen et al 2006).
Respiratory chain enzyme assays
The liquid nitrogen frozen portion of the 600 g super-
natant was thawed and used for measurement of the
maximal activity of the complexes I (CI), II (CII), III (CIII),
and IV (CIV) and citrate synthase (CS), as described by
Rodenburg (Rodenburg 2011).
Statistical analysis
Statistical analysis was performed using Prism 5 (GraphPad
Software Inc., La Jolla, Ca). Normal distribution of the
datasets was confirmed using Lilliefors test. Results were
expressed as mean ± SD and comparisons between groups
were performed using a two way analysis of variance
(ANOVA) and Bonferroni’s post test. Statistical significance
was set at (p<0.05).
Results
In mitochondrial enzyme diagnostics, the activity of CS,
which is an indicator of mitochondrial mass, is used for nor-
malization between mitochondria-enriched preparations
(Rodenburg 2011). The CS activity per mg protein was the
same forWTandKOmice and did not change upon isoflurane
anesthesia (Fig. 1). In the remainder of this paper all values are
expressed per mg protein.
The maximal rate of ATP production was significantly de-
creased by 26 % in untreated KO as compared to untreated
WT (Fig. 2a). Unexpectedly, isoflurane anesthesia significant-
ly increased this rate in both WT and KO by 52 and 69 %,
respectively. The maximal rate of pyruvate oxidation
revealed a tendency to be lower in untreated KO as
compared to untreated WT and isoflurane anesthesia
tended to increase this rate in both WT and KO by 26
and 50 %, respectively (Fig. 2b). To evaluate the effi-
ciency by which the oxidation of pyruvate was coupled to
the production of ATP, we calculated the ratio of ATP produc-
tion to pyruvate oxidation. The ratios obtained showed
similar values for untreated and treated WT and KO mice
(Fig. 2c).
Analysis of the maximal activity of CI, revealed a signifi-
cant decrease by 30 % in isoflurane-treated WT as compared
to untreated WT (Fig. 3a). As expected, this activity was vir-
tually absent in untreated KO and isoflurane treatment did not
lead to any alteration. The maximal activity of CII, was similar
between untreated WTand untreated KO (Fig. 3b). Isoflurane
anesthesia significantly increased this activity by 37 and 50 %
in WT and KO, respectively. The same results were obtained
for CIII (Fig. 3c). Isoflurane anesthesia significantly increased
the maximal activity of this complex by 37 and 40 % in WT
and KO, respectively. For CIV, no difference in maximal ac-
tivity was observed between untreated WT and untreated KO
(Fig. 3d). Although isoflurane anesthesia tended to increase
this activity in both WT (17 %) and KO (16 %), no statistical
significance was reached.
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Fig. 1 Effect of isoflurane on citrate synthase activity. Untreated and
isoflurane-treated WT and KO mice were sacrificed at PD 31–34 and a
mitochondria-enriched fraction was prepared from total brain. Citrate
synthase activity was measured and expressed per mg protein. The data
presented show the absence of any difference between the four
experimental conditions. The data presented are the mean ± SD of 5
WT and 5 KO untreated and 5 WT and 7 KO isoflurane-treated
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Discussion
Previous work with the NDUFS4 KOmouse model of human
CI deficiency showed a decrease in respiratory rate (Quintana
et al 2012a, b; Roelofs et al 2014) and heart rate (Quintana
et al 2012a, b) in the later stages of the disease. The respiratory
rate of the KO mice used in this study decreased from 130 at
PN 22–25 days to 83 at PN 31–34 days (Roelofs et al 2014).
This decrease in respiratory rate was paralleled by neurologi-
cal complications that progressed with age (Quintana et al
2010). Although a decrease in respiratory rate suggests ATP
shortage, other disease mechanisms remain to be considered,
including increased production of reactive oxygen species
(Koopman et al 2013) and triggering of innate immune re-
sponses (Yu et al 2015).
Here, we show that maximal ATP production from pyru-
vate and malate is 25 % decreased in a mitochondria-enriched
fraction from KO mice brain at PN 31–34 days. The same
observation was reached in another NDUFS4 KO mouse
model (Leong et al 2012). At first glance, this relatively mod-
erate decrease seems difficult to reconcile with the virtually
complete absence of active CI in a freeze-thawed aliquot of
this mitochondria-enriched fraction (see also, Kruse et al 2008
and Calvaruso et al 2012). However, there is evidence that
CIII stabilizes NDUFS4-lacking CI to provide partial activity
(Calvaruso et al 2012). This stabilization may be lost upon
freeze-thawing of the mitochondria-enriched fraction.
Intriguingly, isoflurane anesthesia of KO mice restored brain
mitochondrial ATP production to WT levels. This result indi-
cates that the underlying process does not involve irreversible
damage, as is thought to occur at increased levels of reactive
oxygen species. It is tempting to speculate that isoflurane im-
proves the stabilization of NDUFS4-lacking CI by CIII.
The most intriguing observation of the present study is that
isoflurane anesthesia increased rather than decreased brain
mitochondrial ATP production in both WT and CI-deficient
KO mice. To our best knowledge, this is the first report that
describes such an effect of a volatile anesthetic, see also (Miro
et al 1999). A recent in vivo study showed that isoflurane
anesthesia decreased ATP levels in mouse brain (Wang et al
2015). Together, these data lead us to postulate that isoflurane
acts outside the mitochondrion to reduce the supply of pyru-
vate, which is the main mitochondrial substrate in brain.
The increase in brain mitochondrial ATP production ob-
served in anesthetized WT and KO mice was paralleled by a
tendency to increase for the pyruvate oxidation rate, whereas
the CS activity remained unaltered. This may suggest that
pyruvate dehydrogenase is not the rate-limiting enzyme in
the untreated condition. Isoflurane anesthesia significantly in-
creased the activities of CII and CIII and tended to increase the
activity of CIV. This may suggest that the activity of the RC is
rate-limiting in the untreated condition and that isoflurane can
simultaneously increase their activity by a hitherto unknown
mechanism, which may, however, be triggered by ATP short-
age (see above). In sharp contrast, the activity of CI was sig-
nificantly decreased in anesthetized WT mice, indicating that
this enzyme is not rate-limiting in the untreated condition.
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Fig. 2 Effect of isoflurane on ATP production. Untreated and isoflurane-
treated WTand KOmice were sacrificed at PD 31–34 and a mitochondria-
enriched fraction was prepared from total brain. The rates of ATP produc-
tion and pyruvate oxidation were measured at non-rate-limiting
concentrations of pyruvate, malate, ADP, and creatine and expressed per
mg protein. a The ATP production rate measured under these conditions
was significantly decreased in untreated KO as compared to untreated WT
(indicated with a* as compared with a). Isoflurane anesthesia significantly
increased this rate in both WTand KO. b The maximal pyruvate oxidation
rate tended to be decreased in untreated KO and increased in isoflurane-
treated WT and KO. However, none of these differences reached statistical
significance. c The ratio of the rate of ATP production to that of pyruvate
oxidation, reflecting the coupling efficiency, was not significantly different
between the different experimental conditions. The data presented are the
mean ± SD of the number of animals indicated in the caption to Fig. 1.
Statistical significance is displayed as * (p<0.5) and ** (p<0.01)
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Analysis of the ratio of ATP production to pyruvate oxida-
tion revealed similar values for WTand CI-deficient KO mice
regardless whether they were anesthetized or not. This result
indicates, firstly, that the absence of the NDUFS4 subunit does
not alter the coupling of pyruvate oxidation to ATP production
and, secondly, that in vivo exposure to isoflurane does not
alter this efficiency. Pyruvate oxidation is measured in the
presence of an excess of pyruvate and malate, which is con-
verted into oxaloacetate to trap acetyl-CoA, and an excess of
ADP, which is converted into ATP. Under these conditions, a
decreased efficiency of the coupling of pyruvate oxidation to
ATP production would be indicative of an increased proton
leak across the inner mitochondrial membrane. The present
finding that in vivo exposure to isoflurane does not alter the
coupling efficiency is of relevance since in vitro studies
showed that direct addition of halothane to isolated mitochon-
dria caused a limited uncoupling at concentrations between
0.5 and 2 % used clinically to achieve anesthesia (Miller and
Hunter 1970).
Thus far, only inhibitory effects of volatile anesthetics
on mitochondrial ATP production have been reported
(Miller and Hunter 1970; Harris et al 1971). Available
evidence indicates that volatile anesthetics act directly
on CI (Kayser et al 2011) to decrease its activity (Miller
and Hunter 1970; Harris et al 1971). Crucially, these stud-
ies employ direct application of the anesthetic to isolated
mitochondria. For example, halothane, was shown to
dose-dependently inhibit the rate of ADP-stimulated oxy-
gen consumption in the presence of CI-, but not CII-
linked substrates (Miller and Hunter 1970). Direct appli-
cation of halothane to deoxycholate-treated mitochondria
confirmed that CI, and not CII, was the primary target of
the anesthetic (Harris et al 1971). The present study
shows that the in vitro activity of CI was also decreased
after in vivo exposure. The inhibitory effect in direct ap-
plication studies was reversed in less than 5 min (Miller
and Hunter 1970; Harris et al 1971), indicating that the
mechanism of inhibition must be different from that in the
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Fig. 3 Effect of isoflurane on the enzymatic activities of the
mitochondrial respiratory chain complexes. Untreated and isoflurane-
treated WT and KO mice were sacrificed at PD 31–34 and a
mitochondria-enriched fraction was prepared from total brain. The
activities of the four respiratory chain complexes were measured under
non-rate-limiting substrate conditions and expressed per mg protein. The
values obtained reflect the maximum catalytic capacities of the
complexes. a As expected, KO brain was virtually devoid of CI activity
(indicated with a** as compared with a). Isoflurane anesthesia
significantly decreased this activity in WT. b The activity of CII did not
differ between WT and KO. Isoflurane anesthesia significantly increased
this activity to the same extent in both WTand KO. c The activity of CIII
was the same for WT and KO and also in this case isoflurane anesthesia
increased this activity to the same extent in both WT and KO. d Also the
activity of CIV was the same for WT and KO. Isoflurane anesthesia
tended to increase this activity in both cases but this effect did not reach
statistical significance. The data presented are the mean ± SD of the
number of animals indicated in the caption to Fig. 1. Statistical
significance is displayed as ** (p<0.01) and *** (p<0.001)
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present study. Our finding of a sustained effect of volatile
anesthetics is corroborated by a recent study showing that
4 h of anesthesia at the larval stage of C. elegans caused a
marked reduction of the chemotactic response at day 4 of
life (Gentry et al 2013). Also in this study, it was ob-
served that the degree of reduction was significantly more
in worms with a loss-of-function mutation in a CI gene
than in wild type worms.
Unfortunately, our anesthesia protocol does not allow
to draw conclusions on whether the effects of isoflurane
anesthesia at PN 31–34 days are acute or whether, and, if
so, to which extent, they are a consequence of processes
triggered during the first period of isoflurane anesthesia at
PN 22–25 days. Long-term effects of volatile anesthetics
have been reported in the literature and can be neuropro-
tective, as observed in a variety of animal stroke models,
reviewed in (Burchell et al 2013) or neurotoxic, as evi-
denced by animal studies showing that volatile anesthesia
can trigger widespread cell death in the neonatal develop-
ing brain (Jevtovic-Todorovic et al 2003; Yon et al 2005;
Istaphanous et al 2011; Istaphanous et al 2013; Xiong
et al 2013).
A l imi ta t ion of our s tudy is tha t we used a
mitochondria-enriched fraction from whole brain homog-
enate. Since regional susceptibilities to mitochondrial dys-
function have been reported within the CNS (Leong et al
2012; Pinto et al 2012; Quintana et al 2012a, b), a further
detailed investigation should involve specific regions of
the brain. Thus, from the results presented in this study,
we conclude that isoflurane exposure might preserve the
ATP production capacity in brain mitochondria of CI-
deficient KO mice and that the isoflurane hypersensitivity
in these mice, is not a consequence of ATP deficits in the
brain.
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